Cm Management, LLC Lantern Pharma Inc. Transaction History
Cm Management, LLC
- $108 Million
- Q2 2024
A detailed history of Cm Management, LLC transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Cm Management, LLC holds 80,000 shares of LTRN stock, worth $293,600. This represents 0.35% of its overall portfolio holdings.
Number of Shares
80,000
Previous 65,000
23.08%
Holding current value
$293,600
Previous $572,000
34.79%
% of portfolio
0.35%
Previous 0.5%
Shares
10 transactions
Others Institutions Holding LTRN
# of Institutions
41Shares Held
1.26MCall Options Held
42.8KPut Options Held
5.6K-
Vanguard Group Inc Valley Forge, PA364KShares$1.33 Million0.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA157KShares$576,6450.01% of portfolio
-
Geode Capital Management, LLC Boston, MA86.3KShares$316,8930.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny81.8KShares$300,2060.0% of portfolio
-
Davenport & CO LLC63.8KShares$234,1970.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $39.7M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...